Search

Public Health Scotland (PHS) is working with NHS Boards in Scotland, UK Health Security Agency (UKHSA) and other public health agencies across the UK to investigate an increase in the number of Shiga toxin-producing E. coli (STEC) cases across the UK in recent weeks.

Part 13 - items in respect of which endorsements on the grounds of short supply are permitted for the stated month

This release by Public Health Scotland (PHS) reports on systemic anti-cancer therapy (SACT) activity across NHS services in Scotland. Treatment activity includes the weekly number of appointments and the monthly and annual number of appointments and patients receiving treatment.

This report presents provisional information on laboratory reports of norovirus in Scotland compared to the same time last year and the average for the same time period of the previous five years.

This statistical disclosure control protocol describes considerations of risk that should be applied when data is being released, including into the public domain

Part 1 (annex A) - list of groups of items and individual items on the zero discount list

Part 1 (annex A) - list of groups of items and individual items on the zero discount list

Part 17 - list of items which may be supplied to eligible patients as part of the Pharmacy First Scotland scheme

Additions and deletions made to the Tariff over the last 12 months

Part 7 - unbranded medicinal products and ingredients for which a price has been agreed for the current month